β-葡聚糖用于上呼吸道感染症状和心理健康
本申请涉及β-葡聚糖用于上呼吸道感染症状和心理健康。本发明进行了涉及安慰剂对照的双盲设计的研究,以便评价β-葡聚糖组合物对上呼吸道感染和心理健康的效果。在这些研究的报道周期期间,基于POMS调查,治疗组中的受试者具有更少的URTI症状、更好的整体健康状况和更积极的心理评价。 Studies involving placebo-controlled, double-blinded designs to evaluate the effect of beta-glucan compositions on upper-respiratory tract infections and psycholo...
Saved in:
| Format | Patent |
|---|---|
| Language | Chinese |
| Published |
23.11.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
| Summary: | 本申请涉及β-葡聚糖用于上呼吸道感染症状和心理健康。本发明进行了涉及安慰剂对照的双盲设计的研究,以便评价β-葡聚糖组合物对上呼吸道感染和心理健康的效果。在这些研究的报道周期期间,基于POMS调查,治疗组中的受试者具有更少的URTI症状、更好的整体健康状况和更积极的心理评价。
Studies involving placebo-controlled, double-blinded designs to evaluate the effect of beta-glucan compositions on upper-respiratory tract infections and psychological wellness were carried out. During the course of the reporting periods of these studies, subjects in the treatment groups reported fewer URTI symptoms, better overall health and a more positive psychological assessment based on a POMS survey. |
|---|---|
| Bibliography: | Application Number: CN201510514507 |